Management of Atopic Dermatitis in Children Younger Than Two Years of Age by Community Pediatricians: A Survey and Chart Review

J Pediatr. 2020 Jun;221:138-144.e3. doi: 10.1016/j.jpeds.2020.02.015. Epub 2020 Mar 11.

Abstract

Objectives: To characterize primary care providers' (PCPs) practice patterns for atopic dermatitis (AD) in children <2 years old and determine the need for AD guidelines for PCPs focused on this age group.

Study design: This is a mixed-methods study consisting of a survey and a retrospective medical record review of PCP practices in the Chicago metropolitan area. The survey was analyzed using both quantitative and qualitative methods.

Results: In the survey (n = 52 respondents), PCPs reported management of AD is different in children <2 years compared with older children (88%). They were more likely to refer to a specialist (65%) and less likely to use high-potency topical corticosteroids (64%). In the chart review, PCP visits for children 2-5 years old (n = 50 914) vs those <2 years old (n = 71 913) for AD, older children had medium- and high-potency topical corticosteroids prescribed more frequently than younger children (0.66% vs 0.37%, P < .01 and .15% vs 0.05%, P < .01, respectively). In the subset of children <2 years of age who also were evaluated by a specialist (n = 109), medium- and high-potency topical corticosteroids were prescribed disproportionately at visits to providers in dermatology (57%) vs allergy (30%) vs pediatrics (15%) (P < .01). PCPs suggested that guidelines for this age group should include recommendations for preferred corticosteroids (39%), allergy management (35%), referral criteria (22%), and assessment of disease severity (11%).

Conclusions: PCP management of AD in children <2 years is different from older children, with possible underuse of medium/high-potency topical corticosteroids. Clear guidelines for this age group are needed.

Keywords: atopic dermatitis; eczema; physicians' practice patterns; primary healthcare; surveys and questionnaires.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Topical
  • Boron Compounds / therapeutic use
  • Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
  • Calcineurin Inhibitors / therapeutic use
  • Child, Preschool
  • Dermatitis, Atopic / drug therapy*
  • Dermatitis, Atopic / epidemiology*
  • Drug Prescriptions / statistics & numerical data
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Male
  • Pediatricians*
  • Practice Patterns, Physicians' / statistics & numerical data*
  • Primary Health Care
  • Referral and Consultation / statistics & numerical data
  • Retrospective Studies
  • Severity of Illness Index
  • Surveys and Questionnaires
  • United States / epidemiology

Substances

  • Boron Compounds
  • Bridged Bicyclo Compounds, Heterocyclic
  • Calcineurin Inhibitors
  • Glucocorticoids
  • crisaborole